Skip to content

house · Committee report

H. Rept. 118-524

PUBLIC HEALTH EMERGENCY MEDICAL SUPPLIES ENHANCEMENT ACT OF 2023

2024-05-23

Committees

Associated legislation

Text

Purpose and Summary

Introduced on February 24, 2023, by Representative Juan Vargas, H.R. 1166, the Public Health Emergency Medical Supplies Enhancement Act of 2023, amends sections of the Defense Production Act (DPA) (50 U.S.C. Sec. 4501-4568) to, among other things, identify certain materials as scarce and critical during a public health emergency period. The bill would also authorize the prioritization of materials for the federal government to exclude state, local, or tribal purchases and creates an outreach representative position to work with the private sector. Finally, the bill would direct the President to issue a report on the authorities exercised and to provide briefings four months after the submission of the report.

Background and Need for Legislation

The DPA allows the President to require companies to prioritize and accept contracts to meet national defense requirements. The DPA also allows for the President to incentivize production through loans, loan guarantees, and purchase commitments. The COVID-19 pandemic underscored the potential for infectious disease to undermine U.S. national security interests. Together with Operation Warp Speed, the Trump Administration used the DPA 18 times to accelerate the delivery of COVID-19 therapeutics and related equipment. H.R. 1166 is designed to ensure that materials essential for national defense are covered by the DPA during a public health emergency. The bill also provides clarity when federal purchases may appear to conflict with certain state, local, or tribal deliveries. HEARING Pursuant to clause 3(c)(6) of rule XIII, the following hearing was used to develop H.R. 1166: The Committee on Financial Services held a hearing on February 7, 2023, titled ``Combatting the Economic Threat from China.''

Committee Consideration

The Committee on Financial Services met in open session on February 28, 2023, and ordered H.R. 1166 to be reported favorably to the House as amended by a recorded vote of 30 ayes to 2 nays (Record vote no. FC-23), a quorum being present. Before the question was called to order the bill favorably reported, the Committee adopted an amendment in the nature of a substitute offered by Mr. Vargas by voice vote.

Committee Votes

Clause 3(b) of rule XIII of the Rules of the House of Representatives requires the Committee to list the record votes on the order to report legislation and amendments thereto. H.R. 1166 was ordered reported favorably to the House as amended by a recorded vote of 30 ayes to 2 nays (Record vote no. FC-23), a quorum being present. [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] COMMITTEE OVERSIGHT FINDINGS Pursuant to clause 3(c) of rule XIII of the Rules of the House of Representatives, the findings and recommendations of the Committee based on oversight activities under clause 2(b)(1) of rule X of the Rules of the House of Representatives, are incorporated in the descriptive portions of this report. PERFORMANCE GOALS AND OBJECTIVES Pursuant to clause 3(c)(4) of rule XIII of the Rules of the House of Representatives, the goal of H.R. 1166 is to require the identification of certain materials as scarce and critical during a public health emergency period. The bill would also authorize the prioritization of materials for the federal government to exclude state, local, or tribal purchases and creates an outreach representative position to work with the private sector. CONGRESSIONAL BUDGET OFFICE ESTIMATES Pursuant to clause 3(c)(3) of rule XIII of the Rules of the House of Representatives, the following is the cost estimate provided by the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974: [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] During the coronavirus pandemic the Administration--through a series of executive orders--used authorities under the Defense Production Act of 1950 (DPA) to require businesses to prioritize performance and delivery on contracts and orders from the federal government.\1\ It also used the act's authorities to support manufacturing of medical supplies and vaccines, fund projects to expand domestic production of personal protective equipment (PPE), and partner with private companies to distribute PPE. --------------------------------------------------------------------------- \1\See, for example, ``America's Supply Chains,'' Executive Order 14017, 86 Fed. Reg. 11849 (February 24, 2021), https://tinyurl.com/ bdhmc8kc; ``A Sustainable Public Health Supply Chain,'' Executive Order 14001, 86 Fed. Reg. 7219 (January 21, 2021), https://tinyurl.com/ 2pa3b7af; ``Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States,'' Executive Order 13944, 85 Fed. Reg. 49929 (August 6, 2020), https:// tinyurl.com/yupmducj; ``Delegating Additional Authority Under the Defense Production Act With Respect to Health and Medical Resources to Respond to the Spread of COVID-19,'' Executive Order 13911, 85 Fed. Reg. 18403 (March 27, 2020), https://tinyurl.com/mr2p7c56; and ``Prioritizing and Allocating Health and Medical Resources to Respond to the Spread of COVID-19,'' Executive Order 13909, 85 Fed. Reg. 16227 (March 18, 2020), https://tinyurl.com/bdehbd47. --------------------------------------------------------------------------- H.R. 1166 would amend the DPA to specifically incorporate some of the effects of those orders. The bill also would authorize the Federal Emergency Management Agency (FEMA) to appoint an outreach representative to work with industry during public health emergencies. FEMA and the Department of Health and Human Services established a position that fulfilled that requirement as part of the Supply Chain Stabilization Task Force, which manages critical shortages of PPE, ventilators, and pharmaceutical materials by coordinating with industry partners. Because H.R. 1166 would codify current practices, CBO estimates that implementing those provisions would not affect the federal budget. The bill also would require the Administration to report regularly to the Congress during public health emergencies, detailing its use of authorities under the DPA. On the basis of information about similar reports, CBO estimates that satisfying that requirement would cost less than $500,000 over the 2023-2028 period; any spending would be subject to the availability of appropriated funds. CBO has not reviewed H.R. 1166 for intergovernmental or private-sector mandates. Section 4 of the Unfunded Mandates Reform Act excludes from the application of that act any legislative provisions that are necessary for national security. CBO has determined that the provisions of the Defense Production Act of 1950, as amended by the bill, would fall under that exclusion. The CBO staff contacts for this estimate are Caroline Dorminey (for federal costs) and Brandon Lever (for mandates). The estimate was reviewed by Chad Chirico, Deputy Director of Budget Analysis. Phillip L. Swagel, Director, Congressional Budget Office. NEW BUDGET AUTHORITY, ENTITLEMENT AUTHORITY, AND TAX EXPENDITURES Pursuant to clause 3(c)(2) of rule XIII of the Rules of the House of Representatives, the Committee adopts as its own the estimate of new budget authority, entitlement authority, or tax expenditures or revenues contained in the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1973. FEDERAL MANDATES STATEMENT Pursuant to section 423 of the Unfunded Mandates Reform Act of 1995, the Committee adopts as its own estimate the Federal mandates as prepared by the Director of the Congressional Budget Office. ADVISORY COMMITTEE STATEMENT No advisory committees within the meaning of section 5(b) of the Federal Advisory Committee Act were created by this legislation. APPLICABILITY TO LEGISLATIVE BRANCH The Committee finds that the legislation does not relate to the terms and conditions of employment or access to public services or accommodations within the meaning of section 102(b)(3) of the Congressional Accountability Act. EARMARK IDENTIFICATION Pursuant to clause 9 of rule XXI of the Rules of the House of Representatives, the Committee has carefully reviewed the provisions of the bill and states that the provisions of the bill do not contain any congressional earmarks, limited tax benefits, or limited tariff benefits within the meaning of the rule. DUPLICATION OF FEDERAL PROGRAMS Pursuant to clause 3(c)(5) of rule XIII of the Rules of the House of Representatives, the Committee states that no provision of the bill establishes or reauthorizes a program of the Federal Government known to be duplicative of another Federal program, including any program that was included in a report to Congress pursuant to section 21 of the Public Law 111-139 or the most recent Catalog of Federal Domestic Assistance. SECTION-BY-SECTION ANALYSIS OF THE LEGISLATION Sec. 1: Short title This Act may be cited as the ``Public Health Emergency Medical Supplies Enhancement Act of 2023.'' Sec. 2: Public health emergencies This section would amend the Defense Production Act (50 U.S.C. Sec. 4501-4568) to identify certain materials as scarce and critical during an emergency period, as determined by Secretary of the Health and Human Services or the Secretary of Homeland Security. The bill also authorizes the prioritization of materials for the federal government to exclude state, local, or tribal purchases and creates an outreach representative position to work with the private sector. Sec. 3: Report on activities involving small business This section directs the President to issue a report on the authorities exercised and to provide briefings four months after the submission of the report. [all]

Source: https://api.congress.gov/v3/committee-report/118/hrpt/524